Holding(s) in Company

RNS Number : 2739L

Dechra Pharmaceuticals PLC

07 January 2009

 



TR-1:              Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Dechra Pharmaceuticals Plc

2. Reason for notification (yes/no)
An acquisition or disposal of voting rights	yes
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached	no
An event changing the breakdown of voting rights	no
Other (please specify):______________	no

3. Full name of person(s) subject to notification obligation:	Standard Life Investments Ltd
4. Full name of shareholder(s) (if different from 3):	Vidacos Nominees
5. Date of transaction (and date on which the threshold is crossed or reached if different):	6 January 2009
6. Date on which issuer notified:	7 January 2009
7. Threshold(s) that is/are crossed or reached:	6%

8: Notified Details
A: Voting rights attached to shares
Class/type of shares If possible use ISIN code	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of shares	Number of voting rights	Number of shares	Number of voting rights		Percentage of voting rights
				Direct	Indirect	Direct	Indirect
GB0009633180	3,615,473	3,615,473	3,989,722	1,210,474	2,779,248	1.848%	4.244%

B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/ conversion period/date	No. of voting rights that may be acquired (if the instrument exercised/converted)	Percentage of voting rights

Total (A+B)
Number of voting rights	Percentage of voting rights
3,989,722	6.092%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Standard Life Investments Ltd

Proxy Voting:
10. Name of proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:
14 Contact name:	[e-mail] Standard Life Investments Ltd
15. Contact telephone number:	[phone]

For notes on how to complete form TR-1 please see the FSA website. 

 

END

 

 

HOLDGGGMDNMGLZM